Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer by YAN WU, ZHAOJING ZHONG, KOO, Henry, MANGALAMPALLI, Venkata R. M, LUDWIG, Dale L, TONRA, James R, HICKLIN, Daniel J, HUBER, James, BASSI, Rajiv, FINNERTY, Bridget, CORCORAN, Erik, HUILING LI, NAVARRO, Elizabeth, BALDERES, Paul, JIMENEZ, Xenia

Get full text

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeut... by Loizos, Nick, Xu, Yan, Huber, Jim, Liu, Meilin, Lu, Dan, Finnerty, Bridget, Rolser, Robin, Malikzay, Asra, Persaud, Anita, Corcoran, Erik, Deevi, Dhanvanthri S, Balderes, Paul, Bassi, Rajiv, Jimenez, Xenia, Joynes, Christopher J, Mangalampalli, Venkata R M, Steiner, Philipp, Tonra, James R, Wu, Yan, Pereira, Daniel S, Zhu, Zhenping, Ludwig, Dale L, Hicklin, Daniel J, Bohlen, Peter, Witte, Larry, Kussie, Paul

Get full text

Increased production of a secreted glycoprotein in engineered CHO cells through amplification of a transcription factor by MANGALAMPALLI, Venkata R. M, MOWRY, Mark C, LIPSCOMB, Matthew L, JAMES, Rohaizah I, JOHNSON, Alyssa K, KOMPALA, Dhinakar S

Get full text

A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity by Lu, Dan, Zhang, Haifan, Koo, Henry, Tonra, James, Balderes, Paul, Prewett, Marie, Corcoran, Eric, Mangalampalli, Venkata, Bassi, Rajiv, Anselma, Deborah, Patel, Dipa, Kang, Xiaoqiang, Ludwig, Dale L., Hicklin, Daniel J., Bohlen, Peter, Witte, Larry, Zhu, Zhenping

Get full text

CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines by Mangalampalli, Venkata R, Wycuff, Dyane, Chen, Mingzhong, Berlinger, David, Scheideman, Elizabeth H, Menon, Amritha, Fabozzi, Guilia, Hussain, Althaf, Schwartz, Richard M

Get full text